Pharma industry stocks gain on the BSE amid hopes of revenue growth

12 Sep 2023 Evaluate

Stocks related to the pharma industry were trading higher on the BSE, as Crisil in its latest report has said the Indian pharmaceuticals industry is expected to log in a revenue growth of 8-10 per cent in current fiscal (FY24) aided by a steady domestic growth and increased exports to regulated markets, even as semi-regulated markets face headwinds. It stated a study of 186 drug makers, which accounted for about half of the Rs 3.7 lakh crore annual revenue of the sector last fiscal, indicates as much.

Sun Pharmaceutical Industries is currently trading at Rs. 1151.25, up by 14.15 points or 1.24% from its previous closing of Rs. 1137.10 on the BSE.

Natco Pharma is currently trading at Rs. 822.65, up by 10.30 points or 1.27% from its previous closing of Rs. 812.35 on the BSE.

Aurobindo Pharma is currently trading at Rs. 868.05, up by 0.35 points or 0.04% from its previous closing of Rs. 867.70 on the BSE.


Sun Pharma Inds. Share Price

1826.10 -11.20 (-0.61%)
09-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1826.10
Dr. Reddys Lab 1371.60
Cipla 1488.15
Lupin 2251.80
Zydus Lifesciences 1009.40
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.